Fukuda Denshi Co., Ltd.

Tokyo Stock Exchange 6960.T

Fukuda Denshi Co., Ltd. EBITDA Margin for the year ending March 31, 2024: 26.19%

Fukuda Denshi Co., Ltd. EBITDA Margin is 26.19% for the year ending March 31, 2024, a 5.37% change year over year. EBITDA Ratio is the proportion of Earnings Before Interest, Taxes, Depreciation, and Amortization to total revenue, assessing a company's operational profitability before non-operating expenses and non-cash charges.

Fukuda Denshi Co., Ltd. EBITDA Margin for the year ending March 31, 2023 was 24.85%, a 3.48% change year over year.
Fukuda Denshi Co., Ltd. EBITDA Margin for the year ending March 31, 2022 was 24.02%, a 25.11% change year over year.
Fukuda Denshi Co., Ltd. EBITDA Margin for the year ending March 31, 2021 was 19.20%, a 20.24% change year over year.
Fukuda Denshi Co., Ltd. EBITDA Margin for the year ending March 31, 2020 was 15.96%, a 1.06% change year over year.

Key data

Date	EBITDA Margin	EBIT Margin	Depreciation and Amortization	EBIT

Tokyo Stock Exchange: 6960.T

Fukuda Denshi Co., Ltd.

CEO	Mr. Kotaro Fukuda
IPO Date	Jan. 4, 2000
Location	Japan
Headquarters	2-35-8 Hongo
Employees	3,443
Sector	Healthcare
Industries Medical Instruments Hardware & Electronics Telehealth

Description

Fukuda Denshi Co., Ltd. engages in manufacture and sale of medical instruments in Japan and internationally. It offers resting electrocardiograph products; data management software; stress test products; and patient monitoring systems, including central and bedside monitors, transmitters, and central viewer workstations; and vascular screening systems. The company was founded in 1939 and is based in Tokyo, Japan.

Key trends

Past 5 years